V58L (p.Val58Leu) variant of NPPA (Natriuretic peptides A)

V58L (p.Val58Leu) in NPPA (Natriuretic peptides A) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.05 / 1. The record also includes population frequency data and structural context.

V58L (p.Val58Leu) variant details